EPISODE · Nov 28, 2023 · 39 MIN

A Noble Goal

from ACR Journals On Air · host The American College of Rheumatology

End-stage renal disease is a dangerous reality for those who suffer from Lupus Nephritis (LN), despite improvements in immunosuppressive therapy in the last 20 years. Our next guest, Dr. Brad H Rovin, MD, FACP, FASN, is the first author of the manuscript "Kidney-Related Outcomes and Steroid-Sparing Effects in Patients with Active Lupus Nephritis Treated with Obinutuzumab: A Post Hoc Analysis of a Phase 2 Trial." which was recently published in Arthritis & Rheumatology. This study was a post hoc analysis of the NOBILITY trial and was conducted to assess kidney-related outcomes in patients using Obinutuzumab.

Episode metadata supplied by the publisher feed · Published Nov 28, 2023

Embed this episode

Attribution link and audio player

Ready to play

A Noble Goal

0:00 39:36

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ACR Journals On Air?

This episode is 39 minutes long.

When was this ACR Journals On Air episode published?

This episode was published on November 28, 2023.

Can I download this ACR Journals On Air episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!